These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3981857)

  • 1. [Hypotensive effect and tolerability of a short course of treatment with prazosin (pratsiol) and hydralazine (apressin) in a cooperative study of new drugs for the prevention of arterial hypertension].
    Kardiologiia; 1985 Jan; 25(1):23-8. PubMed ID: 3981857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of prazosin with hydralazine in patients receiving hydrochlorothiazide. A randomized, double-blind clinical trial.
    Circulation; 1981 Oct; 64(4):772-9. PubMed ID: 7023744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies with prazosin--a new effective hypotensive agent. II. Two double-blind cross-over studies comparing the effects of prazosin and hydrallazine.
    Hua AS; Macdonald IM; Myers JB; Fang P; Kincaid-Smith P
    Med J Aust; 1977 Jul; 2(1):5-9. PubMed ID: 331040
    [No Abstract]   [Full Text] [Related]  

  • 4. [Peripheral vasodilators in the treatment of hypertension. A review].
    Rasmussen K
    Ugeskr Laeger; 1979 Jan; 141(5):312-4. PubMed ID: 760314
    [No Abstract]   [Full Text] [Related]  

  • 5. [Methodologic approach to individual evaluation of the pharmacodynamic effects of single doses of hydralazine, endralazine, prazosine and propranolol in hypertension patients].
    Izotov AI; Postol'nikov SF; Vygodin VA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):79-85. PubMed ID: 6732937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral vasodilatation in the treatment of hypertension. Prazosin compared with hydralazine in patients not responding to beta-receptor blockade.
    Malmberg L; Fagerberg SE; Frithz G
    Acta Med Scand Suppl; 1982; 665():121-4. PubMed ID: 6760680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Change in the spectrum of lipids and apoproteins A1 and B as affected by hypothiazide and pratsiol in patients with hypertension].
    Oganov RG; Mustafaev II; Perova NV; Postol'nikov SF; Metel'skaia VA
    Kardiologiia; 1985 Aug; 25(8):17-22. PubMed ID: 4068453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydralazine and prazosin in the treatment of hypertension.
    Vandenburg MJ; Sharman VL; Wright P; Drew PJ; Barnes JN
    Br J Clin Pharmacol; 1983 Nov; 16(5):537-42. PubMed ID: 6357257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypotensive agents. Part I: Vasodilators.
    Romankiewicz JA
    J Pract Nurs; 1979 Jun; 29(6):10-2. PubMed ID: 255614
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic value of pratsiol and its effect on indicators of central and peripheral hemodynamics in patients with hypertension].
    Erina EV; Panfilov VV; Prokopova TN; D'iakonova EG; Beliakova EV
    Kardiologiia; 1984 Jul; 24(7):52-6. PubMed ID: 6482157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension. II. The results of combined therapy. Side effects. The reasons for dropouts. Conclusion].
    Metelitsa VI; Filatova NP
    Ter Arkh; 1991; 63(8):35-41. PubMed ID: 1792613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of a beta adrenergic blocking agent nadolol (corgard) in prevention of arterial hypertension: a 6-month treatment (cooperative study)].
    Metelitsa VI; Filatova NP
    Kardiologiia; 1990 May; 30(5):8-14. PubMed ID: 2202853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical effect of pratsiol in arterial hypertension].
    Kasherininov IuR
    Klin Med (Mosk); 1985 Feb; 63(2):67-9. PubMed ID: 3887023
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies with prazosin--a new effective hypotensive agent. III. An acute double-blind cross-over study comparing the effects of single doses of prazosin and hydrallazine in combination with propranolol and a diuretic.
    Hua AS; Myers JB; Kincaid-Smith P
    Med J Aust; 1978 Jan; 1(1):45-8. PubMed ID: 368538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prazosin in hypertension with and without methyldopa.
    Kochar MS; Zeller JR; Itskovitz HD
    Clin Pharmacol Ther; 1979 Feb; 25(2):143-8. PubMed ID: 365428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of obzidan and pratsiol therapy on the blood plasma lipid profile and on the high- and low-density lipoprotein apoproteins in hypertension patients].
    Oganov RG; Mustafaev II; Perova NV; Metel'skaia VA; Postol'nikov SF
    Kardiologiia; 1985 Apr; 25(4):44-8. PubMed ID: 4021272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive drug combinations: prazosin, hydrochlorothiazide and clonidine.
    Pitkäjärvi T; Kyöstilä S; Kontro J; Mattila MJ
    Ann Clin Res; 1977 Oct; 9(5):296-300. PubMed ID: 356719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regional and central hemodynamic changes during the treatment of hypertension with obsidan, apressin and their combination].
    Erina EV; Ozovko GI
    Kardiologiia; 1981 Mar; 21(3):14-9. PubMed ID: 7230593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind cross-over comparison of hydralazine and prazosin in hypertensive subjects on a beta-adrenoceptor blocking agent (atenolol).
    Jones JV; Steiner JM
    Br J Clin Pharmacol; 1980 Nov; 10(5):531-3. PubMed ID: 7437268
    [No Abstract]   [Full Text] [Related]  

  • 20. The addition of prazosin to standard triple therapy in the treatment of severe hypertension.
    Heagerty AM; Russell GI; Bing RF; Thurston H; Swales JD
    Br J Clin Pharmacol; 1982 Apr; 13(4):539-41. PubMed ID: 7066169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.